Scope
Reference
DAC128/0525PM
Description
The intended contract is for the supply of Canakinumab to Northern Health and Social Care Trust for up to a maximum of 3 years
Contract 1. Canakinumab
Supplier
Contract value
- £120,000 excluding VAT
- £144,000 including VAT
Above the relevant threshold
Award decision date
4 July 2025
Standstill period
- End: 18 August 2025
- 8 working days
Earliest date the contract will be signed
19 August 2025
Contract dates (estimated)
- 19 August 2025 to 31 May 2028
- 2 years, 9 months, 13 days
Main procurement category
Goods
CPV classifications
- 33600000 - Pharmaceutical products
Contract locations
- UKN - Northern Ireland
Procedure
Procedure type
Direct award
Supplier
NOVARTIS PHARMACEUTICALS UK LIMITED
- Companies House: 00119006
- Public Procurement Organisation Number: PJTX-5182-QVLR
2nd Floor, The Westworks Building White City Place
London
W12 7FQ
United Kingdom
Email: commercial.pricing@novartis.com
Website: https://www.novartis.com/uk-en/
Region: UKI33 - Kensington & Chelsea and Hammersmith & Fulham
Small or medium-sized enterprise (SME): No
Voluntary, community or social enterprise (VCSE): No
Supported employment provider: No
Public service mutual: No
Contract 1. Canakinumab
Contracting authority
Northern Health And Social Care Trust
- Public Procurement Organisation Number: PBRP-6676-CQZY
Brettan Hall, Antrim Area Hospital, Bush Road
Antrim
BT41 2RL
United Kingdom
Region: UKN0D - Antrim and Newtownabbey
Organisation type: Public authority - central government
Devolved regulations that apply: Northern Ireland